TFIIA-β Antibodies

Santa Cruz Biotechnology delivers a wide array of TFIIA-β monoclonal antibodies for research focused on understanding this essential transcription factor. TFIIA-β monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFIIA-β is crucial for the initiation of transcription by RNA polymerase II, playing a significant role in the regulation of gene expression. Its function is vital in cellular processes such as development, differentiation, and response to environmental signals. Understanding TFIIA-β's mechanisms can provide insights into various diseases and potential therapeutic targets. Researchers can explore TFIIA-β's involvement in transcriptional regulation across different cell types and conditions. Advanced visualization techniques using fluorescent conjugates such as horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) enable detailed examination of TFIIA-β localization and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing molecular biology knowledge and developing new therapeutic strategies.